PROCEPT BioRoboticsĀ® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

Go back to PROCEPT BioRoboticsĀ® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance
(NASDAQ: PRCT) Delayed: 21.19 -1.57 (6.9%)
Previous Close $22.76    52 Week High
Open $22.49    52 Week Low
Day High $22.56    P/E N/A 
Day Low $21.18    EPS
Volume 264,878